Study of ALXN1830 Administered Subcutaneously in Adults With Generalized Myasthenia Gravis
Clinical trial NCT04982289 · WITHDRAWN
Trial details
- NCT number
- NCT04982289
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-01
- Primary completion
- 2023-01-31
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.